| ²é¿´: 2454 | »Ø¸´: 8 | |||
| µ±Ç°Ö»ÏÔʾÂú×ãÖ¸¶¨Ìõ¼þµÄ»ØÌû£¬µã»÷ÕâÀï²é¿´±¾»°ÌâµÄËùÓлØÌû | |||
ÎÂÎÂˮгæ (³õÈëÎÄ̳)
|
[ÇóÖú]
Image JÈí¼þ¶ÔÄÉÃ×Á£½øÐÐÁ£¾¶Í³¼Æ²¢»æÖÆÈýάͼÆ× ÒÑÓÐ1È˲ÎÓë
|
||
| ÎÄÏ×Öп´µ½ÓÐÈËÓÃImage JÈí¼þ¶ÔSEMµÄͼƬµÄÄÉÃ×Á£¾¶½øÐÐͳ¼Æ·ÖÎö£¬²¢»æÖÆÁËÈýάͼÆ×£¬±¾ÈË¿´Á˺ܶàImage JµÄ½Ì³Ì£¬µ«»¹ÊDz»Ã÷°×ÈçºÎ×ö³öÀ´µÄ£¬Ï£ÍûÖªµÀµÄÈËÖ¸µãһϡ£ |
» ÊÕ¼±¾ÌûµÄÌÔÌûר¼ÍƼö
Êý¾Ý´¦ÀíÓë¿ÆÑлæÍ¼ |
» ²ÂÄãϲ»¶
ÕÐÉú¸ºÔð_ԺʿÍŶÓ_ѧÉú¸ß×ÔÓɶȳɳ¤_Éó¤Ñ§ÉúÅàÑø
ÒѾÓÐ5È˻ظ´
ÎÂÖÝ´óѧÕÐÊÕ2026ÄêÈëѧ²©Ê¿Ñо¿Éú£¨»¯Ñ§¡¢²ÄÁÏ¡¢»·¾³£©
ÒѾÓÐ10È˻ظ´
½ðÊô²ÄÁÏÂÛÎÄÈóÉ«/·ÒëÔõôÊÕ·Ñ?
ÒѾÓÐ161È˻ظ´
·Ç¾§ºÏ½ð
ÒѾÓÐ2È˻ظ´
ԺʿÍŶÓ-ÿ½ìѧÉú¶¼ÓÅÐã-¸ß×ÔÓɶÈ-ÍŶӷÕΧºÃ
ÒѾÓÐ0È˻ظ´
Çóµ÷¼Á
ÒѾÓÐ3È˻ظ´
»¯¹¤Ñ§Ôº£¨Ñ§ÔºÕýʽµ÷¼ÁȺ+ÁªÏµ·½Ê½£©
ÒѾÓÐ0È˻ظ´
»¯¹¤Ñ§Ôº£¨Ñ§Ôº¹Ù·½Èº£©-ԺʿÍŶÓÕÐÉú-ѧÉú×ÔÓɶȸß-ÅàÑøÄ£Ê½³ÉÊì¸ßЧ
ÒѾÓÐ0È˻ظ´
ºÚÁú½´óѧ·ÖÎö»¯Ñ§Õе÷¼Á
ÒѾÓÐ0È˻ظ´
Î人¸ßУ¹ú¼Ò¼¶È˲ÅÍŶÓÕÐÊÕ²ÄÁÏ£¬»¯Ñ§£¬·ÄÖ¯µÈרҵ˶ʿµ÷¼ÁÉú
ÒѾÓÐ26È˻ظ´
·Ä´ó»¯¹¤Ñ§Ôº£¨¹Ù·½Èº£©-ԺʿÍŶÓÕÐÉú-ѧÉú×ÔÓɶȸ߷¢Õ¹ºÃ-ÅàÑøÄ£Ê½³ÉÊì
ÒѾÓÐ0È˻ظ´
» ±¾Ö÷ÌâÏà¹ØÉ̼ÒÍÆ¼ö: (ÎÒÒ²ÒªÔÚÕâÀïÍÆ¹ã)
ÎÂÎÂË®
гæ (³õÈëÎÄ̳)
- Ó¦Öú: 0 (Ó×¶ùÔ°)
- ½ð±Ò: 20.4
- É¢½ð: 5
- Ìû×Ó: 29
- ÔÚÏß: 7.1Сʱ
- ³æºÅ: 3461734
- ×¢²á: 2014-10-08
- רҵ: ΢ÉúÎï×ÊÔ´Óë·ÖÀàѧ
7Â¥2016-02-24 21:09:43
ÎÂÎÂË®
гæ (³õÈëÎÄ̳)
- Ó¦Öú: 0 (Ó×¶ùÔ°)
- ½ð±Ò: 20.4
- É¢½ð: 5
- Ìû×Ó: 29
- ÔÚÏß: 7.1Сʱ
- ³æºÅ: 3461734
- ×¢²á: 2014-10-08
- רҵ: ΢ÉúÎï×ÊÔ´Óë·ÖÀàѧ
2Â¥2016-02-24 10:05:20
papaverme
Ìú¸Ëľ³æ (ÕýʽдÊÖ)
- MN-EPI: 4
- Ó¦Öú: 139 (¸ßÖÐÉú)
- ½ð±Ò: 11021.4
- ºì»¨: 15
- Ìû×Ó: 654
- ÔÚÏß: 535.5Сʱ
- ³æºÅ: 408325
- ×¢²á: 2007-06-21
- רҵ: ±íÃæ¡¢ÐÎ̬ÓëÐÎò·ÖÎö
3Â¥2016-02-24 10:19:15
ÎÂÎÂË®
гæ (³õÈëÎÄ̳)
- Ó¦Öú: 0 (Ó×¶ùÔ°)
- ½ð±Ò: 20.4
- É¢½ð: 5
- Ìû×Ó: 29
- ÔÚÏß: 7.1Сʱ
- ³æºÅ: 3461734
- ×¢²á: 2014-10-08
- רҵ: ΢ÉúÎï×ÊÔ´Óë·ÖÀàѧ
|
http://xueshu.baidu.com/s?wd=paperuri%3A%2869dd61ab33533704cbaaf015d94b4c69%29&filter=sc_long_sign&sc_ks_para=q%3DTPGS2k%2FPLGA%20Nanoparticles%20for%20Overcoming%20Multidrug%20Resistance%20by%20Interfering%20Mitochondria%20of%20Human%20Alveolar%20Adenocarcinoma%20Cells.&tn=SE_baiduxueshu_c1gjeupa&ie=utf-8 |
4Â¥2016-02-24 12:28:31













»Ø¸´´ËÂ¥
